Cervical Hydatidiform Moles Pregnancy: Diagnosis and Treatment
DOI:
https://doi.org/10.3889/oamjms.2021.7562Keywords:
Partial cervical hydatidiform mole, Blighted ovum, Pregnancy, Diagnosis, TherapyAbstract
Cervical partial hydatidiform mole is a rare condition and difficult to diagnose. A 39-year-old Balinese woman from Sanglah General Hospital, Bali, Indonesia complained vaginal bleeding with abdominal pain. The patient was diagnosed with a partial hydatidiform mole based on physical examination, ultrasound, beta HCG levels and pathology examinations. Mass evacuation surgery followed by arterial ligation to stop the bleeding and periodically examination of beta HCG levels was carried out until the 14th week after the procedure. Beta HCG decreased gradually to normal level and indicate no risk of trophoblastic malignancy. Establishing the early diagnosis significantly affects the outcome of patient.
Keywords: partial cervical hydatidiform mole, blighted ovum, pregnancy, diagnosis, therapy.
Downloads
Metrics
Plum Analytics Artifact Widget Block
References
Hui P, Buza N, Murphy KM, Rennett BM. Hydatidiform moles: Genetic basis and precision diagnosis. Annu Rev Pathol. 2017;12:449-85. https://doi.org/10.1146/annurev-pathol-052016-100237 PMid:28135560
Salehi S, Eloranta S, Johansson AL, Bergstrom M, Lambe M. Reporting and incidence trends of hydatidiform mole in Sweden 1973-2004. Acta Oncol. 2011;50(3):367-72. https://doi.org/10.3109/0284186X.2010.512922 PMid:21395467
Dhanda S, Ramani S, Thakur M. Gestational trophoblastic disease: A multimodality imaging approach with impact on diagnosis and management. Radiol Res Pract. 2014;2014:842751. https://doi.org/10.1155/2014/842751 PMid:25126425
Allen SD, Lim AK, Seckl MJ, Blunt DM, Mitchell AW. Radiology of gestational trophoblastic neoplasia. Clin Radiol. 2006;61(4):301-13. https://doi.org/10.1016/j.crad.2005.12.003 PMid:16546459
Elsayes KM, Trout AT, Friedkin AM, Liu PS, Bude RO, Platt JF, et al. Imaging of the placenta: A multimodality pictorial review. Radiographics. 2009;29(5):1371-91. https://doi.org/10.1148/rg.295085242 PMid:19755601
Jain KA. Gestational trophoblastic disease: Pictorial review. Ultrasound Q. 2005;21(4):245-53. https://doi.org/10.1097/01.ruq.0000191658.95192.89 PMid:16344728
Sebire NJ, Seckle MJ. Gestational trophoblastic disease: Current management of hydatidiform mole. BMJ. 2008;337:a1193. https://doi.org/10.1136/bmj.a1193 PMid:18708429
Hui P, Baergen R, Cheung A, Fukunaga M, Gersell D, Lage JM, et al. Gestational trophoblastic disease. In: Kurman RJ, Carcangiu ML, Herrington CS, Young RH, editors. WHO Classification of Tumours of Female Reproductive Organs. Vol. 6. Geneva: World Health Organization; 2014. p. 155-67.
Sebire NJ, Foskett M, Fisher RA, Rees H, Seckl M, Newlands E. Risk of partial and complete hydatidiform molar pregnancy in relation to maternal age. BJOG. 2002;109(1):99-102. https://doi.org/10.1111/j.1471-0528.2002.t01-1-01037.x PMid:11843379
Eagles N, Sebire NJ, Short D, Savage PM, Seckl MJ, Fisher RA. Risk of recurrent molar pregnancies following complete and partial hydatidiform moles. Hum Reprod. 2015;30(9):2055-63. https://doi.org/10.1093/humrep/dev169 PMid:26202916
Murdoch S, Djuric U, Mazhar B, Seoud M, Khan R, Kuick R, et al. Mutations in NALP7 cause recurrent hydatidiform moles and reproductive wastage in humans. Nat Genet. 2006;38(3):300-2. https://doi.org/10.1038/ng1740 PMid:16462743
Qian J, Deveault C, Bagga R, Xie X, Slim R. Women heterozygous for NALP7/NLRP7 mutations are at risk for reproductive wastage: Report of two novel mutations. Hum Mutat. 2007;28(7):741. https://doi.org/10.1002/humu.9498 PMid:17579354
Kou YC, Shao L, Peng HH, Rosetta R, del Gaudio D, Wagner AF, et al. A recurrent intragenic genomic duplication, other novel mutations in NLRP7 and imprinting defects in recurrent biparental hydatidiform moles. Mol Hum Reprod 2008;14(1):33-40. https://doi.org/10.1093/molehr/gam079 PMid:18039680
Williams D, Hodgetts V, Gupta J. Recurrent hydatidiform moles. Eur J Obstet Gynecol Reprod Biol. 2010;150(1):3-7. https://doi.org/10.1016/j.ejogrb.2010.01.003 PMid:20171777
Parry DA, Logan CV, Hayward BE, Shires M, Landolsi H, Diggle C, et al. Mutations causing familial biparental hydatidiform mole implicate C6orf221 as a possible regulator of genomic imprinting in the human oocyte. Am J Hum Genet. 2011;89(3):451-58. https://doi.org/10.1016/j.ajhg.2011.08.002 PMid:21885028
Reddy R, Akoury E, Nguyen NM, Abdul-Rahman OA, Dery C, Gupta N, et al. Report of four new patients with proteintruncating mutations in C6orf221/KHDC3L and colocalization with NLRP7. Eur J Hum Genet. 2013;21(9):957-64. https://doi.org/10.1038/ejhg.2012.274 PMid:23232697
Aytan H, Caliskan AC, Demirturk F, Koseoglu RD, Acu B. Cervical partial hydatidiform molar pregnancy. Gynecol Obstet Invest. 2008;66(2):142-4. https://doi.org/10.1159/000141647 PMid:18583920
Betel C, Atri M, Arenson A, Khalifa M, Osborne R, Tomlinson G. Sonographic diagnosis of gestational trophoblastic disease and comparison with retained products of conception. J Ultrasound Med. 2006;25(8):985-93. https://doi.org/10.7863/jum.2006.25.8.985 PMid:16870892
Schwentner L, Schmitt W, Bartusek G, Kreienberg B, Herr D. Cervical hydatidiform mole pregnancy after missed abortion presenting with severe vaginal bleeding: Case report and review of the literature. Eur J Obstet Gynecol Reprod Biol. 2011;156(1):9-11. https://doi.org/10.1016/j.ejogrb.2010.12.029 PMid:21272989
Hancock BW. Staging and classification of gestational trophoblastic disease. Best Pract Res Clin Obstet Gynaecol. 2003;17(6):869-83. https://doi.org/10.1016/s1521-6934(03)00073-7 PMid:14614886
Kani KK, Lee JH, Dighe M, Moshiri M, Kolokythas O, Dubinsky T. Gestatational trophoblastic disease: Multimodality imaging assessment with special emphasis on spectrum of abnormalities and value of imaging in staging and management of disease. Curr Probl Diagn Radiol. 2012;41(1):1-10. https://doi.org/10.1067/j.cpradiol.2011.06.002 PMid:22085657
Royal College of Obstetricians and Gynaecologists (RCOG). The Management of Gestational Trophoblastic Disease, Green-Top Guideline No. 38. United Kingdom: Royal College of Obstetricians and Gynaecologists; 2010. p. 1-12.
Kung FT, Chang SY, Tsai YC, Hwang FR, Hsu TY, Soong YK. Subsequent reproduction and obstetric outcome after methotrexate treatment of cervical pregnancy: A review of original literature and collaborative follow up. Hum Reprod. 1997;12(3):591-5. https://doi.org/10.1093/humrep/12.3.591 PMid:9130765
Ginsburg ES, Frates MC, Rein MS, Fox JH, Hornstein MD, Friedman AJ. Early diagnosis and treatment of cervical pregnancy in an in vitro fertilization program. Fertil Steril. 1994;61(5):966-96. https://doi.org/10.1016/s0015-0282(16)56714-4 PMid:8174738
Wee HY, Tay EH, Soong Y, Loh SF. Cervical hydatidiform molar pregnancy. Aust N Z J Obstet Gynaecol. 2003;43(6):473-4. https://doi.org/10.1046/j.0004-8666.2003.00132.x PMid:14712955
Ng TY, Wong LC. Diagnosis and management of gestational trophoblastic neoplasia. Best Pract Res Clin Obstet Gynaecol. 2003;17(6):893-903. https://doi.org/10.1016/s1521-6934(03)00098-1 PMid:14614888
Ngan H, Bender H, Benedet JL, Jones H, Montruccoli GC, Pecorelli S, et al. Gestational trophoblastic neoplasia, FIGO 2000 staging and classification. Int J Gynaecol Obstet. 2003;3 Suppl 1:175-7. https://doi.org/10.1016/s0020-7292(03)90120-2 PMid:14763174
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2021 I Gede Sastra Winata, Popy Kusuardiyanto, Made Bagus Dwi Aryana, Ryan Mulyana (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0)
